GLP 1 Drug Biosimilar Market Size, Share & Trends Analysis by Reference Biologic (Semaglutide Biosimilar, Liraglutide Biosimilar, Exenatide Biosimilar, Dulaglutide Biosimilar), by Formulation (Injectable Pen, Oral Tablet, Patch & Implant), by Distribution (Retail Pharmacy, Mail-Order & Specialty Pharmacy, Hospital & Clinic), and Segment Forecasts, 2026 to 2035 GLP-1 biosimilars are biological medicines developed to be highly similar in quality, safety, and efficacy to the originator GLP-1 receptor agonists, such as semaglutide, liraglutide, and dulaglutide
Its effectiveness isnt just about the vitaminits also about where its injected
They work by stimulating your pituitary gland to release more GH
Weight loss tablets are expected to be a game changer, making GLP-1 treatments feel more accessible for a whole new group of people, especially those who dont like needles, or dont want to inject themselves every week
However, this method may not be as effective as injections